Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2025-11-12 Interim / Quarterly Rep…
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
LIFE: Lifecare ASA Q3 2025 results - Attachment: Q3 2025 Report.pdf
Interim / Quarterly Report Classification · 1% confidence The document is a 'Q3 2025' report for Lifecare Group. It contains detailed financial statements, key figures, operational reviews, and management commentary for the third quarter. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q3 2025
2025-11-12 English
LIFE: Lifecare ASA Q3 2025 results
Earnings Release Classification · 1% confidence The document is an announcement from Lifecare ASA regarding their Q3 2025 financial results. It provides key highlights, operational updates, and financing information, and explicitly states that it is submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. While it summarizes results, it functions as the initial announcement of the quarterly report release rather than the full, comprehensive financial report itself. Given the length (under 5,000 characters) and the nature of the disclosure as a regulatory announcement of results, it fits the criteria for a Report Publication Announcement (RPA). Q3 2025
2025-11-12 English
Lifecare ASA (LIFE): Invitation to presentation of Q3 2025 results - Attachment: Lifecare ASA (LIFE)- Invitation to presentation of Q3 2025 results.pdf
Report Publication Announcement Classification · 1% confidence The document is an invitation to a presentation of Q3 2025 results, scheduled for a future date (November 12, 2025). It does not contain the actual financial results, but rather announces the timing and logistics for the upcoming earnings release and presentation. Per the 'Menu vs Meal' rule, an announcement regarding the release of a report is classified as a Report Publication Announcement (RPA).
2025-11-06 English
Lifecare ASA (LIFE): Invitation to presentation of Q3 2025 results
Report Publication Announcement Classification · 1% confidence The document is an invitation to a presentation of Q3 2025 results, scheduled for a future date. It does not contain the actual financial results, but rather announces the timing and logistics for the upcoming release and presentation. According to the 'Menu vs Meal' rule, an announcement regarding the timing or release of a report is classified as a Report Publication Announcement (RPA).
2025-11-06 English
Lifecare shares key learnings from ongoing longevity study LFC-SEN-002 - Attachment: Lifecare shares key learnings from ongoing longevity study LFC-SEN-002.pdf
Regulatory Filings Classification · 1% confidence The document is a press release from Lifecare ASA providing an update on the progress and findings of a specific clinical/longevity study (LFC-SEN-002). It details technical refinements, biocompatibility results, and future development timelines. Since it does not fit into specific financial reporting categories like 10-K, ER, or IR, and is not a report publication announcement, it falls under the general regulatory announcement category for corporate updates.
2025-11-05 English
Lifecare shares key learnings from ongoing longevity study LFC-SEN-002
Environmental & Social Information Classification · 1% confidence The document is a press release from Lifecare ASA providing an update on the progress and findings of a specific clinical/longevity study (LFC-SEN-002). It details technical results, biocompatibility, and future development milestones. As it is a general corporate announcement regarding operational/R&D progress that does not fit into specific financial reporting categories like 10-K, ER, or IR, it is classified as a Regulatory Filing (RNS).
2025-11-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.